tiprankstipranks
Alaunos Therapeutics (TCRT)
NASDAQ:TCRT
US Market

Alaunos Therapeutics (TCRT) Financial Statements

693 Followers

Alaunos Therapeutics Financial Overview

Alaunos Therapeutics's market cap is currently $6.94M. The company's EPS TTM is $; its P/E ratio is -1.51; Alaunos Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 5.00K$ 10.00K$ 5.00K$ 2.92M$ 398.00K
Gross Profit$ 5.00K$ 10.00K$ -4.80M$ 2.92M$ 398.00K
Operating Income$ -4.22M$ -4.81M$ -34.27M$ -35.10M$ -77.55M
EBITDA$ -4.22M$ -4.68M$ -30.90M$ -31.82M$ -74.97M
Net Income$ -4.18M$ -4.68M$ -35.14M$ -37.73M$ -78.75M
Balance Sheet
Cash & Short-Term Investments$ 1.39M$ 1.09M$ 6.06M$ 39.06M$ 76.05M
Total Assets$ 2.97M$ 2.75M$ 8.26M$ 64.94M$ 94.86M
Total Debt$ 0.00$ 0.00$ 0.00$ 20.07M$ 30.09M
Net Debt$ -1.39M$ -1.09M$ -6.06M$ -18.99M$ -45.96M
Total Liabilities$ 813.00K$ 692.00K$ 1.96M$ 26.38M$ 36.81M
Stockholders' Equity$ 2.15M$ 2.06M$ 6.31M$ 38.55M$ 58.06M
Cash Flow
Free Cash Flow$ -2.97M$ -4.97M$ -30.34M$ -29.45M$ -64.79M
Operating Cash Flow$ -2.87M$ -4.97M$ -30.14M$ -29.23M$ -61.47M
Investing Cash Flow$ -98.00K$ 0.00$ 1.35M$ -193.00K$ -3.32M
Financing Cash Flow$ 3.26M$ 0.00$ -18.14M$ 6.37M$ 25.78M
Currency in USD

Alaunos Therapeutics Earnings and Revenue History

Alaunos Therapeutics Debt to Assets

Alaunos Therapeutics Cash Flow

Alaunos Therapeutics Forecast EPS vs Actual EPS